fda d.i.s.c.o. burst edition: fda approval of tafinlar (dabrafenib) with mekinist (trametinib) fo...
Published 5 months ago • 69 plays • Length 4:01Download video MP4
Download video MP3
Similar videos
-
5:01
fda d.i.s.c.o. burst edition: fda approval of tafinlar (dabrafenib) in combination with mekinist ...
-
5:00
fda d.i.s.c.o.: nivolumab for adjuvant treatment of patients with melanoma
-
1:08
fda approval of adjuvant dabrafenib/trametinib in braf melanoma
-
4:37
tafinlar® (dabrafenib) mekinist® (trametinib) mechanism of action for advanced melanoma
-
11:07
dabrafenib – tafinlar®
-
11:45
to dye or to die - dr. tephilah
-
12:46
clinical trials for ctcl and how to find them
-
2:14
mekinist (trametinib)- unresectable or metastatic melanoma
-
1:35
dabrafenib - tafinlar in a nutshell.
-
6:39
gsk2118436 (dabrafenib) with and without the oral mek1/2 inhibitor gsk1120212 (trametinib)
-
0:30
dr. postow on fda approval of adjuvant dabrafenib plus trametinib in braf-mutant melanoma
-
3:18
dabrafenib plus trametinib for the treatment of mnsclc
-
36:32
tocilucimab: summary of the tocidys study – dr. roland chapurlat
-
1:22
tafinlar (dabrafenib)
-
1:11
dr. weber on the fda approval of adjuvant dabrafenib/trametinib in braf-mutant melanoma
-
13:42
my experience with mekinist side effects, trametinib
-
0:34
fda approves two new melanoma drugs
-
2:34
novartis gets fda approval for skin cancer drug
-
0:48
dr. michael rotkowitz on the dabrafenib plus trametinib combination for melanoma
-
0:15
tafinlar approved for advanced skin cancer
-
1:31
dr. daud on dabrafenib/trametinib vs immunotherapy in melanoma